Background Carbapenem resistance is defined as in vitro non-susceptibility to any
carbapenem and/or documented production of a carbapenemase. This feature has rapidly …

Introduction: In the era of multidrug-resistant, extensively drug-resistant (XDR) and even
pandrug-resistant Gram-negative microorganisms, the medical community is facing the …

A literature review was undertaken to ascertain the molecular basis for tigecycline and
colistin resistance mechanisms and the experimental basis for the detection and delineation …

Carbapenem-resistant Acinetobacter baumannii (CR Ab) is a major cause of health care-
associated infections. CR Ab is typically multidrug resistant, and infection is difficult to treat …

Currently, drug resistance, especially against cephalosporins and carbapenems, among
gram-negative bacteria is an important challenge, which is further enhanced by the limited …

During the past decades, rates of multidrug-resistant (MDR) and carbapenem-resistant (CR)
Enterobacteriaceae clinical isolates, mainly Klebsiella spp., Escherichia coli, Enterobacter …

Carbapenem-resistant Acinetobacter baumannii (CRAB) is endemic in Greece. CRAB
initially emerged in 2000 and since then, carbapenemases still have a crucial role in CRAB …

Objectives A total of 226 carbapenem-resistant Acinetobacter baumannii (CRAB) isolates
was collected during 2014–2016 from inpatients (age range 5–88 years) in four Bulgarian …

Carbapenem-resistant Acinetobacter baumannii (CRAB) constitutes an increasing problem
worldwide. CRAB bacteremia is associated with a high fatality rate and its optimal treatment …

Acinetobacter baumannii is a pathogen of increasing concern, commonly causing outbreaks
in the hospital environment. Of particular concern, A. baumannii strains exhibiting resistance …